Quest Diagnostics Incorporated (DGX)
NYSE • Healthcare
November 20, 2026 at 21:00 UTC
Metrics Over Time
Where the Money Goes
Q3 2026In plain terms: out of every $100 in revenue, Quest Diagnostics Incorporated keeps $10 as net profit.
Fundamentals & Financials
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings
Feb 9
in 79 daysQ1 2027% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS
Quest Diagnostics topped consensus on both revenue and earnings in the third fiscal quarter of 2026, based on preliminary results reported October 22, 2026, with revenue up 10.0% to about $3.1 billion and adjusted EPS of $3.00 topping the $2.87 estimate (+4.5%). On the top line, revenue of $3.097 billion topped the $3.052 billion estimate (+1.5%) as the quarter reflected continued demand across its diagnostic information services footprint, including routine and advanced clinical testing and anatomic pathology. Profitability came through at a gross margin of ~34% and an operating margin of roughly 16%, translating to about $312.0 million of net income, up 27.3% from roughly $245.0 million a year ago. Cash generation was positive, with operating cash flow of about $740.0 million, and Quest returned capital through roughly $150.0 million of share repurchases and about $95.0 million in dividends during the period. For the next period, consensus calls for EPS of $2.68 on revenue of $3.034 billion.
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated (NYSE: DGX) provides diagnostic information services, risk assessment services, and healthcare information technology in the medical diagnostics and research business. The company generated $11.0 billion of revenue in FY2025. Its work spans routine and advanced clinical testing, anatomic pathology, insurance-focused assessments, and software used by healthcare organizations and clinicians.
Today's Snapshot
DGX closed slightly lower at 258.28, in line with a flat sector. Shares changed hands at about half as much again as its usual level. Quest Diagnostics raised its earnings outlook as physician and hospital revenue strengthened.
Trading Volume
Above 10d avg 944.9K
1.3M
vs S&P 500 Today
Strong Outperformance
+3.18%
Updated: November 20, 2026 at 21:24 UTC
Technical Indicators
All signalsHide signals
- EMA (5 indicators)$219.05 - $257.83Buy
- RSI (14)60.76Neutral
- Stochastic %K (14, 3, 3)77.59Neutral
- MACD Level (12, 26)5.05Neutral
Peers & Related Assets
Get premium market insights delivered directly to your inbox.